Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ok now lets some kind of follow through by our Company...

Avot was just sold/merged... the Avot loan was secure by Avot assets..(that where alwritten down)

we granted Avot forbearances on the note which extended through March 5, 2010 to accommodate Avot during the solicitation of its business for a capital raise or sale which concluded with a March 2010 sale of substantially all of Avot’s assets and our collection of $503,111 on the note receivable principal and interest (see Note 17). At February 28, 2010 the balance of the note receivable was $503,111, including accrued interest receivable of $3,111.

.

.

.

Be well

Share
New Message
Please login to post a reply